Nabriva Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update by Seini Moimoi | May 5, 2022 | Portfolio News
Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types by Seini Moimoi | Apr 19, 2022 | Portfolio News
Axonics® Announces Comprehensive Launch of the Axonics F15™ Recharge-Free Sacral Neuromodulation System by Seini Moimoi | Apr 19, 2022 | Portfolio News
